Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1534-1540

  Hilgard, Philip ^a   Treichel, Ulrich ^a   Dries, Volker ^b   Dienes, Hans Peter ^b   Gerken, Guido ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cryoglobulins; Cryoprecipitation; Hepatitis C virus; Hepatocytes; Plasma membranes; Receptor; Viral uptake

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CHRONIC HEPATITIS; CLINICAL ARTICLE; ELECTRON MICROSCOPY; ENDOCYTOSIS; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER; LIVER CELL; LIVER CELL MEMBRANE; MALE; PRIORITY JOURNAL; SERUM; VIRUS CELL INTERACTION;

AGED; CELL MEMBRANE; CELLS, CULTURED; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 25844502527     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902):359-362.
2. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341(8):556-562.
3. Bartenschlager R, Kaul A, Sparacio S: Replication of the hepatitis C virus in cell culture. Antiviral Res 2003; 60(2):91-102.
4. Pietschmann T, Bartenschlager R: Tissue culture and animal models for hepatitis C virus. Clin Liver Dis 2003; 7(1):23-43.
5. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al: Binding of hepatitis C virus to CD81. Science 1998; 282(5390):938-941.
6. Wellnitz S, Klumpp B, Berth H, Ito S, Depla E, Dubuisson J, et al: Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. J Virol 2002; 76(3):1181-1193.
7. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, et al: Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003; 100(12):7271-7276.
8. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96(22):12766-12771.
9. Hilgard P, Stockert R: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 2000; 32(5):1069-1077.
10. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA: CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 2004; 78(3):1448-1455.
11. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, et al: Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 2003; 278(42):41003-41012.
12. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, et al: Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol 2002; 68(2):206-215.
13. Jackson T, Sharma A, Ghazaleh RA, Blakemore WE, Ellard FM, Simmons DL, et al: Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. J Virol 1997; 71(11):8357-8361.
14. Fabrizi F, Pozzi C, Farina M, Dattolo P, Lunghi G, Badalamenti S, et al: Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant 1998; 13(8):1991-1997.
15. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106(5):1291-1300.
16. Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, et al: Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol 1995; 33(11):643-650.
17. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F: Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160(7):3594-3601.
18. Mihm S, Hartmann H, Ramadori G: A reevaluation of the association of hepatitis C virus replicative intermediates with peripheral blood cells including granulocytes by a tagged reverse transcription/polymerase chain reaction technique. J Hepatol 1996; 24(4):491-497.
19. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR: Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 1994; 202(2):606-614.
20. Hubbard AL, Wall DA, Ma A: Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains. J Cell Biol 1983; 96(1):217-229.
21. Pontisso P, Ruvoletto MG, Gerlich WH, Heermann KH, Bardini R, Alberti A: Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 1989; 173(2):522-530.
22. Gladhaug IP, Christoffersen T: Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. Monensin inhibits receptor externalization and reduces the capacity for continued endocytosis of epidermal growth factor. J Biol Chem 1988; 263(25):12199-12203.
23. Larkin JM, Coleman H, Espinosa A, Levenson A, Park MS, Woo B, et al: Intracellular accumulation of pIgA-R and regulators of transcytotic trafficking in cholestatic rat hepatocytes. Hepatology 2003; 38(5):1199-1209.
24. Bender V, Buschlen S, Cassio D: Expression and localization of hepatocyte domain-specific plasma membrane proteins in hepatoma x fibroblast hybrids and in hepatoma dedifferentiated variants. J Cell Sci 1998; 111(Pt 22):3437-3450.
25. Rice CM: Flaviviridae. The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al. (Eds.). Fields Virology. Philadelphia: Lipincott Raven, 1996; pp. 931-959.
26. Gollins SW, Porterfield JS: Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. J Gen Virol 1985; 66(Pt 9):1969-1982.
27. Mady BJ, Kurane I, Erbe DV, Fanger MW, Ennis FA: Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection. J Gen Virol 1993; 74(Pt 5):839-844.
28. Halstead SB, Casals J, Shotwell H, Palumbo N: Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg 1973; 22(3):365-374.
29. Halstead SB: In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140(4):527-533.
30. Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239(4839):476-481.
31. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line [see comments]. Science 1999; 285(5424):110-113.
32. Blight KJ, Kolykhalov AA, Rice CM: Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290(5498):1972-1974.
33. Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T: Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol 1997; 78(Pt 10):2467-2476.
34. Wunschmann S, Medh JD, Klinzmann D, Schmidt WN, Stapleton JT: Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 2000; 74(21):10055-10062.
35. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S, et al: Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 1999; 57(3):223-229.